ADC Therapeutics America, Inc.
$5.1M 4,269 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Jcbd, LLC
Jcbd, LLC reported $5,089,478.86 across General Payments, Research, and Ownership to 10 physicians and teaching hospitals across 12 transactions.
- $5.1M
- All-tracks total
- 12
- Transactions
- 10
- Recipients
- #274
- of 1,925 companies
Jcbd, LLC reported $5,089,478.86 across all CMS Open Payments tracks (General + Research + Ownership) to 10 physicians and teaching hospitals in Program Year 2024 - ranking #274 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $65,300.00, averaging $508.9K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer jcbd-llc Jcbd, LLC
$5.1M · #274/1,925 · 0.0% industry · PY2024
- TOT $5.1M
- RANK #274
- SHARE 0.0%
- TXN 12
- RCP 10
- CAT 1
- GEN $65.3K
- TOP1 100.0%
- PY 2024
Volume peers
Nearest volume peer: ADC Therapeutics America, Inc. ($5.1M)
Jcbd, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Jcbd, LLC
$5,089,478.86: that is what Jcbd, LLC reported in payments to 10 physicians and teaching hospitals during Program Year 2024, spread across 12 transactions ($424.1K per transaction, $508.9K per recipient). The company sits at rank #274 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
"Acquisitions" leads the 1-category general-payment breakdown below at $65.3K (100.0% of General Payments, 10 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 1 types of general payments, Jcbd, LLC's largest category was "Acquisitions" at $65.3K - 100.0% of General Payments.
How Jcbd, LLC divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Acquisitions | $65.3K | 10 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $65,300.00 (100.0%) of $65,300.00 in this company's General Payments records across 1 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Jcbd, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Edward Jeffrey Donner
$65,300.00 across 10 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Jcbd, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Jcbd, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Jcbd, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
BrainScope Company, Inc.
$5.1M 25 recipients
Compare payment profiles
American Medical Technology Inc
$5.1M 0 recipients
Compare payment profiles
Spineart SA
$5.1M 233 recipients
Compare payment profiles
Pristine Surgical LLC
$5.1M 5 recipients
Compare payment profiles
SK Life Science, Inc.
$5.1M 20,538 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.